Platelet-activating factor receptor antagonists
US9029377B2 · kind B2 · utility
0Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 28, 2010 |
| Grant date | May 12, 2015 |
| Priority date | — |
| Expiry date | Jan 5, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG08G5/58
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Cyclohexyl sulfonamide compounds which are platelet-activating factor (PAF) receptor antagonists. Said compounds may be useful, for example, for the treatment of atherosclerosis or other PAF-mediated disorders, including inflammatory, cardiovascular, and immune disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.